News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HyperBranch Medical Technology, Inc. Release: Pivotal Study and New Product Announcement



10/11/2010 11:36:20 AM

DURHAM, N.C.--(BUSINESS WIRE)--HyperBranch Medical Technology, Inc. announced the start of the pivotal portion of the clinical study for Adherus Dural Sealant. This is a key step in the process to gain FDA approval for the product. Enrollment at eight US hospitals began in September 2010 with up to 30 US sites participating in the pivotal trial. The Company successfully completed a U.S. feasibility study for the Adherus Dural Sealant in May, 2010.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES